High
77.420
Open
76.840
VWAP
77.18
Vol
251.76K
Mkt Cap
7.42B
Low
76.690
Amount
19.43M
EV/EBITDA(TTM)
18.48
Total Shares
95.84M
EV
6.78B
EV/OCF(TTM)
16.17
P/S(TTM)
5.66
Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The Company's products are used in content creation, distribution and playback to enhance image and sound quality and improve transmission and playback. Its cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. The Company's other products include three dimensional glasses and kits, broadcast hardware and software. Its technology includes Dolby Atmos, Dolby TrueHD, Dolby Vision and Dolby Digital Plus.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
305.23M
+5.68%
0.713
+0.47%
310.12M
+1.74%
0.773
-4.53%
366.34M
+2.62%
1.150
+0.88%
Estimates Revision
The market is revising No Change the revenue expectations for Dolby Laboratories, Inc. (DLB) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -8.59%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-8.59%
In Past 3 Month
3 Analyst Rating
26.23% Upside
Wall Street analysts forecast DLB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DLB is 97.50 USD with a low forecast of 95.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
26.23% Upside
Current: 77.240
Low
95.00
Averages
97.50
High
100.00
26.23% Upside
Current: 77.240
Low
95.00
Averages
97.50
High
100.00
Rosenblatt
Steven Frankel
Strong Buy
Maintains
$100 → $95
2025-05-02
Reason
Rosenblatt
Steven Frankel
Price Target
$100 → $95
2025-05-02
Maintains
Strong Buy
Reason
Barrington Research
Patrick Sholl
Buy
Maintains
$100
2025-05-02
Reason
Barrington Research
Patrick Sholl
Price Target
$100
2025-05-02
Maintains
Buy
Reason
Barrington Research
Patrick Sholl
Buy
Maintains
$100
2025-02-13
Reason
Barrington Research
Patrick Sholl
Price Target
$100
2025-02-13
Maintains
Buy
Reason
Meeting to be held in Minneapolis on February 11 hosted by Barrington.
Rosenblatt
Steven Frankel
Strong Buy
Maintains
$100
2025-01-30
Reason
Rosenblatt
Steven Frankel
Price Target
$100
2025-01-30
Maintains
Strong Buy
Reason
Barrington Research
Patrick Sholl
Buy
Maintains
$100
2025-01-30
Reason
Barrington Research
Patrick Sholl
Price Target
$100
2025-01-30
Maintains
Buy
Reason
Barrington Research
James Goss
Buy
Maintains
$100
2025-01-27
Reason
Barrington Research
James Goss
Price Target
$100
2025-01-27
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Dolby Laboratories Inc (DLB.N) is 19.45, compared to its 5-year average forward P/E of 22.93. For a more detailed relative valuation and DCF analysis to assess Dolby Laboratories Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
22.93
Current PE
19.45
Overvalued PE
26.15
Undervalued PE
19.71
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
14.49
Current EV/EBITDA
13.70
Overvalued EV/EBITDA
16.17
Undervalued EV/EBITDA
12.80
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
6.08
Current PS
5.44
Overvalued PS
6.89
Undervalued PS
5.28
Financials
Annual
Quarterly
FY2025Q2
YoY :
+1.38%
369.56M
Total Revenue
FY2025Q2
YoY :
+5.17%
111.97M
Operating Profit
FY2025Q2
YoY :
-6.10%
92.23M
Net Income after Tax
FY2025Q2
YoY :
-6.93%
0.94
EPS - Diluted
FY2025Q2
YoY :
-2.60%
168.00M
Free Cash Flow
FY2025Q2
YoY :
+1.05%
90.30
Gross Profit Margin - %
FY2025Q2
YoY :
+2.71%
29.57
FCF Margin - %
FY2025Q2
YoY :
-7.35%
24.96
Net Margin - %
FY2025Q2
YoY :
+28.72%
10.22
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
50.6K
USD
1
3-6
Months
6.5M
USD
5
6-9
Months
12.7M
USD
7
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
200.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
9.9K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
2
125.6K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
8
172.7K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
50.6K
USD
1
3-6
Months
6.5M
USD
5
6-9
Months
12.7M
USD
7
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
200.0
USD
Months
DLB News & Events
Events Timeline
2025-05-01 (ET)
2025-05-01
16:39:17
Dolby sees FY25 non-GAAP EPS $3.88-$4.03, consensus $4.04
2025-05-01
16:37:18
Dolby sees Q3 non-GAAP EPS 62c-77c, consensus 81c
2025-05-01
16:34:45
Dolby reports Q2 non-GAAP EPS $1.34, consensus $1.27
Sign Up For More Events
Sign Up For More Events
News
1.0
05-12PRnewswireDolby Laboratories President and CEO Kevin Yeaman to Host Fireside Chat at the William Blair 45th Annual Growth Stock Conference
9.5
05-02NASDAQ.COMHere's What Key Metrics Tell Us About Dolby Laboratories (DLB) Q2 Earnings
9.5
05-02NASDAQ.COMDOLBY LABORATORIES Earnings Results: $DLB Reports Quarterly Earnings
Sign Up For More News
People Also Watch
CHRD
Chord Energy Corp
95.880
USD
-2.14%
ALV
Autoliv Inc
100.920
USD
-0.69%
SNV
Synovus Financial Corp
49.360
USD
-0.36%
GIL
Gildan Activewear Inc.
49.340
USD
+0.51%
MIDD
Middleby Corp
149.780
USD
+0.71%
TREX
Trex Co Inc
60.030
USD
-0.56%
CAE
CAE Inc
25.650
USD
+4.40%
IVZ
Invesco Ltd
15.320
USD
-1.03%
ICL
ICL Group Ltd
6.780
USD
-0.44%
ASND
Ascendis Pharma A/S
157.540
USD
+0.22%
FAQ
What is Dolby Laboratories Inc (DLB) stock price today?
The current price of DLB is 77.24 USD — it has increased 0.38 % in the last trading day.
What is Dolby Laboratories Inc (DLB)'s business?
What is the price predicton of DLB Stock?
What is Dolby Laboratories Inc (DLB)'s revenue for the last quarter?
What is Dolby Laboratories Inc (DLB)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Dolby Laboratories Inc (DLB)'s fundamentals?
How many employees does Dolby Laboratories Inc (DLB). have?